PlaCor Inc.
This article was originally published in Start Up
Executive Summary
PlaCor is developing a device that assesses the reactivity of platelets in patients who take antiplatelet drugs like aspirin and clopidogrel. The more reactive platelets are, the more likely they are to cause blood clotting in arteries.